Earnings Call · Q2 FY2022·2022-08-04

Q2 22EPS +3.70%·Rev n/aQ1 22EPS +8.11%·Rev n/aQ4 21EPS -7.46%·Rev n/aQ3 21EPS +18.18%·Rev n/a⚠ consensus missing

FATE THERAPEUTICS INC FATE

Scott Wolchko — President and CEO

Ed Dulac — Chief Financial Officer

−0.8%1d on move date−0.7% vs SPY3d+4.1%5d−1.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FATE calls or request research access.

More FATE calls Browse calls Request research access